![]() |
|
|
Vol. 299, Issue 1, 114-120, October 2001
Departments of Pharmacology and Therapeutics (R.L.P., G.F.G., N.D.,
N.E.G.) and Psychiatry (N.E.G.), Louisiana State University Health
Sciences Center, Shreveport, Louisiana
Research from our laboratory has explored the role of the
hypothalamo-pituitary-adrenal (HPA) axis in cocaine reinforcement. These experiments were designed to determine the involvement of the HPA
axis in extinction. Male Wistar rats were trained to self-administer cocaine [0.125, 0.25, or 0.5 mg/kg/infusion (inf)] and food pellets (45 mg) under a multiple, alternating schedule of reinforcement. When
self-administration was stable, saline was substituted for cocaine.
Blood samples were taken at the end of the sessions following cocaine
self-administration, the first exposure to saline substitution (first);
and once the criteria for extinction were met (final). Plasma
corticosterone was measured using radioimmunoassays. Although there was
a significant increase in the number of infusions obtained during the
first saline substitution test by rats trained with 0.5 mg/kg/inf of
cocaine, there was a decrease in infusions received when 0.125 mg/kg/inf of cocaine was tested. Following repeated exposure to the
extinction conditions, responding by rats trained to self-administer
all three doses of cocaine was decreased to similar levels. In
addition, there were significant differences in plasma corticosterone
in rats trained with different doses of cocaine. Lever-pressing
behavior and plasma corticosterone varied during extinction in relation
to the training dose of cocaine and according to whether the rats had
been exposed to single or repeated extinction testing. These data are
discussed in terms of the potential difficulties involved in
interpreting the effects of compounds intended to reduce drug reinforcement.
This article has been cited by other articles:
![]() |
G. A. Carrasco, K. J. Damjanoska, D. N. D'Souza, Y. Zhang, F. Garcia, G. Battaglia, N. A. Muma, and L. D. Van de Kar Short-Term Cocaine Treatment Causes Neuroadaptive Changes in G{alpha}q and G{alpha}11 Proteins in Rats Undergoing Withdrawal J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 349 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Goeders Stress and Cocaine Addiction J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 785 - 789. [Abstract] [Full Text] [PDF] |
||||